Cancer
Immune Ecotypes Could Account for Multiple Myeloma Outcomes Beyond Staging
Multiple myeloma has long been puzzling: two patients with “the same” diagnosis can diverge dramatically in progression and therapy response....
Nebraska Study Links Gut Microbe to Cancer-Fighting Immune Response
A new study led with University of Nebraska–Lincoln researchers reports that metabolites made by specific gut bacteria can strengthen the...
Sustained virtual smoking cessation doubles quit rates for cancer patients
A new randomized clinical trial reports that a community-based smoking cessation program for people receiving cancer care can nearly double...
Researchers Identify Therapeutic Vulnerability in Aggressive Childhood Leukemia
An international research team has pinpointed a new biological weakness in KMT2A-rearranged B-cell acute lymphoblastic leukemia (B-ALL), one of the...
Reactivated DRP1 Enables Resistance to MEK Inhibitors in Pancreatic Cancer Cells
Pancreatic cancer remains notoriously difficult to treat, and targeted therapies often fall short when tumor cells activate escape routes. A...
Second Review Aims to Improve Targeting Accuracy
Double-Tracer “Diagnostic Twins” Could Improve Alpha-Targeted Prostate Cancer Dosing When metastatic prostate cancer outpaces hormonal therapy, clinicians face a narrow...
New Insights into Liver Cancer Gene Signatures for Prognosis and Therapy
Hepatocellular carcinoma (HCC), a formidable global health challenge, continues to exhibit high mortality rates primarily due to insufficient early diagnostic...
Veillonella ratti alters gut microbiome to prevent EAE disease progression
A groundbreaking study published in Experimental & Molecular Medicine unveils the potential of the gut microbiome in combating autoimmune diseases...
New cancer drug demonstrates potential in mesothelioma clinical trial
A groundbreaking study from the University of Vermont has revealed a novel approach to treating mesothelioma, a deadly cancer caused...
Engineered Bifidobacterium offers promise for oral cancer vaccine delivery
Japanese researchers at Kobe University have developed a groundbreaking oral cancer vaccine using genetically engineered Bifidobacterium longum, a probiotic bacterium known...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!